Reishi mushroom is generally well tolerated by healthy adults at typical supplement doses, and serious adverse events are uncommon in clinical studies. That said, “generally safe” is not the same as “safe for everyone,” and the liver risk question deserves a closer look than most supplement labels offer. A handful of case reports tie reishi to acute liver injury, lab research shows it can interfere with how the body processes certain medications, and the supplement industry’s loose quality standards add a layer of uncertainty that clinical trials do not capture.
What Clinical Studies Actually Show About Side Effects
The most rigorous look at reishi in human trials comes from a Cochrane systematic review of its use alongside cancer treatment. Across the studies reviewed, side effects were minimal and included nausea and insomnia. No significant blood-related or liver toxicity was found in the trial data.1Cochrane Database of Systematic Reviews. Ganoderma lucidum (Reishi mushroom) for cancer treatment A broader review of the mushroom’s health applications described a “favorable safety profile with low incidence of side effects.”2Heliyon. Recent advances in Ganoderma lucidum: Bioactive components, health effects, and industrial standardization
Animal data supports this general picture. In a repeated-dose oral toxicity study in rats, reishi extracts at up to 1,000 mg per kilogram of body weight per day caused no injury or dysfunction in the liver or kidney. Researchers measured a wide panel of markers including liver enzymes, inflammatory markers, and kidney function indicators, and found no significant abnormal variations compared to controls.3PLOS ONE. Effects of Mexican Ganoderma lucidum extracts on liver, kidney, and the gut microbiota of Wistar rats: A repeated dose oral toxicity study The same study actually found that reishi extracts had prebiotic effects, increasing bacterial diversity in the gut and positively shifting the balance of major gut bacterial groups.
A cross-sectional survey of cancer patients who used reishi found that longer use was associated with higher rates of symptom improvement. Patients who took reishi for more than five years were roughly twice as likely to report benefits compared to those who had used it for less than a year.4PubMed Central. Symptom improvements and adverse effects with Reishi mushroom use: A Cross-Sectional survey of cancer patients This suggests that for many users, extended consumption does not produce worsening side effects over time, though self-reported survey data has obvious limitations compared to controlled trials.
The Liver Injury Question
Despite the generally reassuring trial data, reishi has appeared in published case reports of acute liver injury, and this is where the safety conversation gets more complicated. A widely cited case involved a 47-year-old man who developed acute hepatitis with dramatically elevated liver enzymes after consuming reishi mushroom powder alongside alcohol. He arrived at the hospital with headache and abdominal pain, and his labs showed significant liver inflammation. He was treated with N-acetylcysteine and IV fluids, and his symptoms and lab values resolved completely within two weeks.5PubMed Central. Ganoderma lingzhi (Reishi Mushroom)-Induced Acute Liver Injury in the Setting of Alcohol Use: A Case Report and Review of the Literature
The alcohol component of that case is worth pausing on. Alcohol is itself a well-known liver stressor, and combining it with a supplement that contains bioactive compounds capable of affecting liver enzyme pathways creates a situation where the liver is essentially processing two challenging substances simultaneously. Whether reishi alone would have caused the same degree of injury in that patient is impossible to know from a single case. But the report underscores an important practical point: if you drink regularly, adding reishi to the mix introduces a variable your liver may not handle cleanly.
It is also worth noting what these case reports are and are not. A case report documents what happened to one person. It cannot prove that reishi caused the liver injury, only that the two events occurred together. Tens of millions of people consume reishi products worldwide, and the number of published hepatotoxicity cases remains very small. That does not make the risk zero, but it does mean that reishi-related liver injury appears to be rare in absolute terms. The people most likely at risk seem to be those combining reishi with alcohol, taking unusually high doses, or using products of uncertain quality.
How Reishi Can Interfere with Medications
One of the less publicized concerns around reishi is its ability to affect how the body metabolizes prescription drugs. Lab research has identified compounds in reishi, specifically its triterpenoids, that inhibit several subtypes of cytochrome P450 enzymes. These are the enzymes your liver uses to break down a wide range of medications, from blood thinners and antidepressants to painkillers and statins. When these enzymes are inhibited, drugs can build up to higher-than-intended levels in the bloodstream, potentially increasing their effects or side effects.6PubMed Central. Triterpenoids from Ganoderma lucidum inhibit cytochrome P450 enzymes interfering with the metabolic process of specific clinical drugs
In that study, researchers built a library of 66 triterpenoid compounds from reishi and tested them against seven different CYP450 enzyme subtypes. Most of the compounds inhibited CYP1A2, and certain individual compounds showed broad inhibitory effects across multiple enzyme types. Two specific compounds interfered with the metabolism of 16 different drugs in laboratory settings.6PubMed Central. Triterpenoids from Ganoderma lucidum inhibit cytochrome P450 enzymes interfering with the metabolic process of specific clinical drugs These findings come from test-tube and animal experiments, so the degree to which they translate to a person taking a standard reishi capsule is uncertain. But the direction of the evidence is clear enough to take seriously if you are on medications metabolized by these pathways.
Blood clotting is another area of concern. Laboratory screening of reishi extract against human platelets and blood coagulation found that it had a dual effect on clotting factors and was cytotoxic to platelets and certain white blood cells.7PubMed Central. The Effect of Mushroom Extracts on Human Platelet and Blood Coagulation: In vitro Screening of Eight Edible Species For someone already taking blood thinners like warfarin or newer anticoagulants, adding reishi could theoretically amplify the anti-clotting effect and raise bleeding risk. This is not a confirmed clinical interaction from human trials, but the biological plausibility is strong enough that most integrative practitioners advise stopping reishi before surgery and being cautious when using it alongside anticoagulant medications.
Animal research has also suggested that reishi can lower blood sugar, which raises a theoretical concern about additive effects when combined with diabetes medications. If you are taking drugs to manage your blood glucose, adding reishi without monitoring could push your levels lower than intended. The evidence here is mostly from animal models, but it is another reason to loop in your prescriber before starting reishi if you are on any chronic medications.
Allergic Reactions and Respiratory Sensitization
Most discussions of reishi safety focus on the liver and drug interactions, but there is a separate concern for people with respiratory allergies. A study of 172 patients with respiratory allergy in India found that roughly 28% showed significant skin reactivity to reishi spore extracts in intradermal tests, and about 17% reacted to whole-body extracts of the fungus. More than 80% of those who tested positive on skin tests also had elevated IgE antibodies specific to reishi.8Clinical & Experimental Allergy. Sensitization to Ganoderma lucidum in patients with respiratory allergy in India
This does not mean that nearly a third of people with allergies will react to reishi supplements. The study tested patients who already had respiratory allergies, and the sensitization was to spore and whole-body proteins, which may differ in concentration from what ends up in a commercial extract. Still, the finding is a useful reminder that reishi is a fungus, and fungi are common allergens. If you have mold or mushroom allergies, reishi products could trigger symptoms ranging from mild nasal congestion to more serious allergic responses. People with confirmed fungal allergies should approach reishi with more caution than the general population.
Immunomodulation and Who Should Be Careful
One of reishi’s most celebrated properties, its ability to modulate the immune system, is also a reason certain people should think twice before using it. Research has documented that fungal metabolites, including those from reishi, can suppress or stimulate different branches of the immune response.9PubMed Central. Antiinflammatory and immunomodulating properties of fungal metabolites For a healthy person, this immune modulation is part of what makes reishi attractive as a supplement. For someone with an autoimmune condition, though, stimulating an already overactive immune system could worsen symptoms. And for someone on immunosuppressive drugs after an organ transplant, anything that alters immune function introduces unpredictable risk.
The evidence here is less about specific case reports and more about biological logic. If a substance demonstrably shifts immune activity, it is not neutral for people whose immune systems are already being carefully managed by medication. This is one area where the usual supplement-industry framing of “it’s natural, so it’s fine” breaks down most clearly.
Product Quality and Contamination
A problem that cuts across the entire supplement industry hits reishi particularly hard: you cannot always be sure what is in the product you buy. Reishi supplements are sold as powders, capsules, tinctures, teas, and extracts, and they are not subject to the same pre-market testing as pharmaceutical drugs. A comprehensive review of reishi’s properties noted that clinical studies on safety, interactions with foods and drinks, chronic use, and potential for causing genetic damage are largely missing.10Phytotherapy Research. Ganoderma lucidum (Reishi) an edible mushroom; a comprehensive and critical review of its nutritional, cosmeceutical, mycochemical, pharmacological, clinical, and toxicological properties
One specific contamination concern is heavy metals. Mushrooms are bioaccumulators, meaning they absorb elements from the soil and substrate they grow on. A risk assessment of reishi grown in Longquan, China, a major production region, measured concentrations of arsenic, cadmium, chromium, copper, mercury, nickel, and lead. While overall exposure risk for the local population was found to be relatively low, chromium concentrations exceeded values reported in previous literature, and the researchers flagged arsenic and chromium as needing further analysis to determine how much was in the more dangerous inorganic forms.11Environmental Geochemistry and Health. Risk assessment of potentially toxic elements exposure through ganoderma lucidum consumption in the population of Longquan, China
For the average consumer buying reishi capsules online, this means the growing conditions, sourcing, and third-party testing matter enormously. Two products labeled “reishi extract 500 mg” might contain very different things depending on whether the mushroom was grown on contaminated substrate, whether the product contains actual fruiting body or just mycelium on grain, and whether the manufacturer tested for heavy metals and microbial contamination. Looking for products that carry third-party certification from organizations like USP, NSF, or ConsumerLab provides at least some assurance, though no guarantee.
Pregnancy, Breastfeeding, and Children
The safety data for reishi in pregnant or breastfeeding women is essentially nonexistent. A review of edible and medicinal mushrooms as sources of bioactive compounds in pregnancy concluded that well-designed prospective studies and randomized controlled trials are still needed to determine safety, efficacy, optimal intake, and the active compounds responsible for any effects.12PubMed Central. Edible and Medicinal Mushrooms as Sources of Bioactive Molecules in Pregnancy: Potential Impact on Preeclampsia and Gestational Diabetes Outcomes In plain terms, no one has done the work to show reishi is safe during pregnancy, and the immunomodulatory and blood-sugar-lowering properties described above are exactly the kind of effects that make a substance worth being cautious about during pregnancy.
The same gap applies to children. Pediatric dosing, safety, and pharmacokinetics for reishi are essentially unstudied. Most of the clinical data that exists comes from adult cancer patients or healthy adults, and extrapolating from those populations to children or pregnant women is not sound practice. Until dedicated studies fill this gap, the reasonable approach for these groups is avoidance.
Practical Guidance for People Considering Reishi
If you are a generally healthy adult not taking medications, the evidence suggests reishi is unlikely to cause you harm at standard supplement doses. The side effects that do appear in trials tend to be mild and digestive in nature, like nausea or loose stools. Insomnia has also been reported. Most people who use reishi long-term report no worsening of side effects over time, and the animal toxicology data is reassuring at doses far exceeding what a human would take in a typical supplement.
The risk profile shifts meaningfully under specific circumstances. People who drink alcohol regularly, take prescription medications metabolized by the liver, use blood thinners, manage diabetes with medication, have autoimmune conditions, have fungal allergies, or are pregnant or breastfeeding all have reason to be more cautious. For these groups, the conversation should happen with a healthcare provider who knows your full medication list and health history, not with a supplement label or an online forum.
Choosing a product matters as much as choosing whether to take reishi at all. The research gaps around long-term human safety, drug interactions at real-world doses, and contamination levels across different commercial products mean that the supplement you pick is doing a lot of the work in determining your actual risk. A well-sourced, third-party-tested extract from fruiting bodies is a different product, biologically speaking, from an untested mycelium-on-grain powder sold by an anonymous overseas vendor, even if both say “reishi” on the label.
What the Research Still Cannot Tell You
The honest limitation of reishi safety research is its shallowness. The Cochrane review that found minimal side effects was working with a small number of trials, most of which were short in duration and focused on cancer patients receiving conventional treatment alongside reishi. The animal toxicity data is rigorous for what it covers but cannot predict rare idiosyncratic reactions in humans. The drug interaction data is almost entirely from test-tube and animal models, meaning we know reishi compounds can inhibit liver enzymes, but we do not know at what real-world dose this becomes clinically meaningful for a person taking a particular medication.
The gap is especially wide around chronic use. While the survey of cancer patients suggested that long-term users fared well, survey data cannot establish safety the way a controlled trial can.4PubMed Central. Symptom improvements and adverse effects with Reishi mushroom use: A Cross-Sectional survey of cancer patients People who experienced problems may have stopped taking reishi and thus never appeared in a survey of current users, a bias known as survivorship bias. There is an active clinical trial evaluating reishi’s effects on liver function markers in people with metabolic-associated fatty liver disease, testing doses of 250 mg and 500 mg of standardized extract over twelve weeks. Results from trials like this will eventually help fill in the picture, but for now, much of what we think we know about reishi safety rests on tradition, limited trial data, and biological plausibility rather than the kind of deep evidence base that exists for well-studied pharmaceuticals.
A comprehensive review put the gap plainly: clinical studies regarding safety and efficacy, interactions with foods and drinks, chronic use, and the potential for causing genetic damage are missing for reishi.10Phytotherapy Research. Ganoderma lucidum (Reishi) an edible mushroom; a comprehensive and critical review of its nutritional, cosmeceutical, mycochemical, pharmacological, clinical, and toxicological properties That does not mean reishi is dangerous. It means the confidence level around its safety is lower than many enthusiasts realize, and higher than many skeptics assume. The mushroom has been consumed for centuries in East Asia, which provides some reassurance about its general tolerability, but traditional use patterns (whole mushroom brewed as tea, consumed in moderate amounts) differ substantially from modern supplement use (concentrated extracts in capsule form, sometimes at high doses, sometimes combined with other supplements or medications). Whether traditional safety translates cleanly to modern products is one of the questions the research has not yet answered.